Ming Yan is CHIEF TECHNOLOGY OFFICER of Cytek Biosciences, Inc.. Currently has a direct ownership of 6.02 Million shares of CTKB, which is worth approximately $34.5 Million. The most recent transaction as insider was on Jun 20, 2023, when has been sold 20,000 shares (Common Stock) at a price of $8.18 per share, resulting in proceeds of $163,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.02M
0.19% 3M change
0.39% 12M change
Total Value Held $34.5 Million

Ming Yan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2023
SELL
Open market or private sale
$163,600 $8.18 p/Share
20,000 Reduced 0.25%
7,850,258 Common Stock
May 19 2023
SELL
Open market or private sale
$143,800 $7.19 p/Share
20,000 Reduced 0.25%
7,870,258 Common Stock
May 18 2023
SELL
Payment of exercise price or tax liability
$17,955 $6.69 p/Share
2,684 Reduced 0.03%
7,890,258 Common Stock
May 18 2023
BUY
Exercise of conversion of derivative security
-
6,889 Added 0.09%
7,892,170 Common Stock
Apr 19 2023
SELL
Open market or private sale
$194,200 $9.71 p/Share
20,000 Reduced 0.25%
7,886,053 Common Stock
Mar 20 2023
SELL
Open market or private sale
$185,799 $9.29 p/Share
20,000 Reduced 0.25%
7,906,053 Common Stock
Feb 21 2023
SELL
Open market or private sale
$218,800 $10.94 p/Share
20,000 Reduced 0.25%
7,926,053 Common Stock
Feb 21 2023
SELL
Payment of exercise price or tax liability
$8,468 $10.97 p/Share
772 Reduced 0.01%
7,946,053 Common Stock
Feb 21 2023
BUY
Exercise of conversion of derivative security
-
1,981 Added 0.02%
7,946,825 Common Stock
Feb 08 2023
SELL
Open market or private sale
$12,136 $13.53 p/Share
897 Reduced 0.01%
7,944,844 Common Stock
Feb 03 2023
SELL
Open market or private sale
$14,752 $13.51 p/Share
1,092 Reduced 0.01%
7,945,741 Common Stock
Jan 19 2023
SELL
Open market or private sale
$220,600 $11.03 p/Share
20,000 Reduced 0.25%
7,946,833 Common Stock
Dec 19 2022
SELL
Open market or private sale
$207,600 $10.38 p/Share
20,000 Reduced 0.25%
7,966,833 Common Stock
Nov 21 2022
SELL
Open market or private sale
$293,200 $14.66 p/Share
20,000 Reduced 0.25%
7,986,833 Common Stock
Nov 18 2022
SELL
Payment of exercise price or tax liability
$11,387 $14.75 p/Share
772 Reduced 0.01%
8,006,833 Common Stock
Nov 18 2022
BUY
Exercise of conversion of derivative security
-
1,981 Added 0.02%
8,007,605 Common Stock
Oct 19 2022
SELL
Open market or private sale
$288,400 $14.42 p/Share
20,000 Reduced 0.25%
8,005,624 Common Stock
Sep 19 2022
SELL
Open market or private sale
$248,400 $12.42 p/Share
20,000 Reduced 0.25%
8,025,624 Common Stock
Aug 19 2022
SELL
Open market or private sale
$272,400 $13.62 p/Share
20,000 Reduced 0.25%
8,045,624 Common Stock
Aug 18 2022
SELL
Payment of exercise price or tax liability
$10,854 $14.06 p/Share
772 Reduced 0.01%
8,065,624 Common Stock
Aug 18 2022
BUY
Exercise of conversion of derivative security
-
1,981 Added 0.02%
8,066,396 Common Stock
Jul 19 2022
SELL
Open market or private sale
$236,600 $11.83 p/Share
20,000 Reduced 0.25%
8,064,415 Common Stock
Jun 21 2022
SELL
Open market or private sale
$201,200 $10.06 p/Share
20,000 Reduced 0.25%
8,084,415 Common Stock
May 19 2022
SELL
Open market or private sale
$198,400 $9.92 p/Share
20,000 Reduced 0.25%
8,104,415 Common Stock
May 18 2022
SELL
Payment of exercise price or tax liability
$9,939 $9.65 p/Share
1,030 Reduced 0.01%
8,124,415 Common Stock
MY

Ming Yan

CHIEF TECHNOLOGY OFFICER
Fremont, CA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB